KRAS mutation analysis in patients (pts) with locally advanced pancreatic cancer (LAPC) treated with gefitinib and chemoradiation therapy (CT-RT) in a phase I trial.

被引：0
|
作者：
Chen, H.
Raben, D.
Schefter, T.
Kane, M.
McCarter, M.
Olsen, C.
McCoy, K.
Eckhardt, S. G.
Gumerlock, P. H.
机构：
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
[2] Univ Colorado, Boulder, CO 80309 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4106
引用
收藏
页码：204S / 204S
页数：1
相关论文
共 50 条
  • [21] Phase I trial of hyperfractionated radiation therapy with taxol as a radiosensitizer in locally advanced pancreatic cancer
    Ashamaila, HL
    Mokhtar, B
    Colella, F
    Selim, H
    Youssef, E
    Rafla, S
    RADIOLOGY, 1998, 209P : 436 - 436
  • [22] Capecitabine chemoradiation (X-RT) as neoadjuvant therapy for patients (pts) with locally advanced breast cancer (LABC) refractory to anthracyclines.
    Gaui, MF
    Amorim, G
    Arcuri, R
    Pereira, G
    Moreira, D
    Djahjah, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 52S - 52S
  • [23] Interim results of a multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC).
    Lacy, Jill
    Portales, Fabienne
    Hammel, Pascal
    Cid, Roberto A. Pazo
    Mozo, Jose Luis Manzano
    Kim, Edward Jae-hoon
    Dowden, Scot D.
    Borg, Christophe
    Sastre, Javier
    Bathini, Venu Gopal
    Terrebonne, Eric
    Lopez-Trabada, Daniel
    Rivera, Fernando
    Asselah, Jamil
    Damiani, Azzurra
    Hwang, Jimmy J.
    Ong, Teng Jin
    Nydam, Thom
    Li, Jack Shiansong
    Philip, Philip Agop
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [24] A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer
    Ikeda, M
    Okada, S
    Tokuuye, K
    Ueno, H
    Okusaka, T
    BRITISH JOURNAL OF CANCER, 2002, 86 (10) : 1551 - 1554
  • [25] A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer
    M Ikeda
    S Okada
    K Tokuuye
    H Ueno
    T Okusaka
    British Journal of Cancer, 2002, 86 : 1551 - 1554
  • [26] Prognostic factors for disease-free and overall survival in patients treated with chemoradiation therapy for locally advanced pancreatic cancer
    Krishnan, S.
    Rana, V.
    Janjan, N.
    Abbruzzese, J.
    Das, P.
    Delclos, M.
    Varadhachary, G.
    Evans, D.
    Wolff, R.
    Crane, C.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S527 - S527
  • [27] Weekly cisplatin/irinotecan and radiotherapy (RT) in patients with locally advanced esophageal cancer : multicenter FFCD phase II trial.
    Michel, P
    Mirabel, X
    Galais, MP
    Dahan, L
    Conroy, T
    Boucher, E
    Oprea, C
    Paillot, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 322S - 322S
  • [28] Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-H gemcitabine infusion, in locally advanced pancreatic cancer
    Maurel, Joan
    Martin-Richard, Marta
    Conill, Carlos
    Sanchez, Marcelo
    Petriz, Lourdes
    Gines, Angels
    Miquel, Rosa
    Gallego, Rosa
    Cajal, Rosana
    Ayuso, Carmen
    Navarro, Salvador
    Marmol, Maribel
    Nadal, Cristina
    Auge, Josep Maria
    Fernandez-Cruz, Laureano
    Gascon, Pere
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (05): : 1391 - 1398
  • [29] Assessment of circulating tumor (ct)DNA in patients (pts) with locally advanced rectal cancer (LARC) pts treated with neoadjuvant therapy (NAT)
    Molinari, C.
    Marisi, G.
    Laliotis, G.
    Spickard, E.
    Rapposelli, I. G.
    Petracci, E.
    George, G. V.
    Sharma, S.
    Jurdi, A.
    Sethi, H.
    Liu, M. C.
    Ulivi, P.
    Canale, M.
    Saragoni, L.
    Panzacchi, R.
    Frassineti, G. L.
    Muratore, M.
    Romeo, A.
    Martinelli, G.
    Passardi, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S428 - S428
  • [30] Neoadjuvant capecitabine chemoradiation (X-RT) for patients (pts) with locally advanced breast cancer (LABC) failing anthracycline-based neoadjuvant therapy: findings from a prospective phase II trial
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 151 - 151
12345